SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories to make equity investment in Sunsure Solarpark

18 Dec 2024 Evaluate

Alkem Laboratories together with its subsidiary M/s. Enzene Biosciences (Enzene) has entered into a Share Subscription and Shareholders’ agreement on December 17, 2024 with M/s. Sunsure Solarpark Twenty Two (Sunsure Solarpark) and M/s. Sunsure Energy for equity investment in Sunsure Solarpark. The said investment will be completed by the end of April, 2025. 

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Alkem Laboratories Share Price

5374.75 -3.25 (-0.06%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: